The estimated Net Worth of Susan Mahony is at least 12.2 百万$ dollars as of 28 April 2023. Susan Mahony owns over 3,913 units of Horizon Therapeutics Plc stock worth over 455,082$ and over the last 15 years he sold HZNP stock worth over 11,451,681$. In addition, he makes 341,789$ as Independent Director at Horizon Therapeutics Plc.
Susan has made over 24 trades of the Horizon Therapeutics Plc stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 3,913 units of HZNP stock worth 455,082$ on 28 April 2023.
The largest trade he's ever made was selling 36,585 units of Horizon Therapeutics Plc stock on 4 December 2017 worth over 3,152,895$. On average, Susan trades about 6,016 units every 74 days since 2009. As of 28 April 2023 he still owns at least 3,913 units of Horizon Therapeutics Plc stock.
You can see the complete history of Susan Mahony stock trades at the bottom of the page.
Dr. Susan M. Mahony serves as Independent Director of the Company. Dr. Mahony serves on the board of directors of Zymeworks Inc., a public biopharma company; Vifor Pharma AG, a public pharmaceutical company; Assembly Biosciences, Inc., a public biotechnology company, and Cereius Inc., a private biotechnology company. Previously, Dr. Mahony served as senior vice president and president of Lilly Oncology and was a member of the executive committee at Eli Lilly and Company from 2009 until her retirement in August 2018. Prior to that, Dr. Mahony served in a variety of leadership roles at Eli Lilly and Company, including president and general manager Lilly Canada, and executive director global development. Dr. Mahony worked in sales and marketing at Bristol-Myers Squibb Company from 1995 to 2000, at Amgen Limited from 1991 to 1995, and at Schering Plough from 1989 to 1991. Dr. Mahony earned bachelor of science and doctorate of philosophy (Ph.D.) degrees in pharmacy, as well as a master of business administration degree from London Business School.
As the Independent Director of Horizon Therapeutics Plc, the total compensation of Susan Mahony at Horizon Therapeutics Plc is 341,789$. There are 14 executives at Horizon Therapeutics Plc getting paid more, with Timothy Walbert having the highest compensation of 13,873,200$.
Susan Mahony is 55, he's been the Independent Director of Horizon Therapeutics Plc since 2019. There are 10 older and 12 younger executives at Horizon Therapeutics Plc. The oldest executive at Horizon Therapeutics Plc is William Daniel, 67, who is the Independent Director.
Susan's mailing address filed with the SEC is C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 22ND FLOOR, NEW YORK, NY, 10007.
Over the last 13 years, insiders at Horizon Therapeutics Plc have traded over 454,905,275$ worth of Horizon Therapeutics Plc stock and bought 11,809,010 units worth 58,823,653$ . The most active insiders traders include Jeff Himawan、Woodlands Health Ventures F...、Jean Francois Formela. On average, Horizon Therapeutics Plc executives and independent directors trade stock every 13 days with the average trade being worth of 12,248,018$. The most recent stock trade was executed by Gino Santini on 2 October 2023, trading 23,092 units of HZNP stock currently worth 351,691$.
at horizon therapeutics, we believe science and compassion must work together to transform lives. we are driven to deliver innovative medicines to those living with rare, autoimmune and severe inflammatory diseases because we uniquely understand the patient journey. for us, success is measured by the numbers that matter most – the number of lives we touch, the number we change and those we work to help save.
Horizon Therapeutics Plc executives and other stock owners filed with the SEC include: